key: cord-0736591-d4qo9sqz
authors: Izurieta, Hector S; Graham, David J; Jiao, Yixin; Hu, Mao; Lu, Yun; Wu, Yue; Chillarige, Yoganand; Wernecke, Michael; Menis, Mikhail; Pratt, Douglas; Kelman, Jeffrey; Forshee, Richard
title: Natural history of COVID-19: Risk factors for hospitalizations and deaths among >26 million U.S. Medicare beneficiaries
date: 2020-12-16
journal: J Infect Dis
DOI: 10.1093/infdis/jiaa767
sha: f045f27bf5b28531fac005c05bcb27fda0dea1f5
doc_id: 736591
cord_uid: d4qo9sqz

BACKGROUND: Evaluate risk factors for severe COVID-19 outcomes among Medicare beneficiaries during the pandemic’s early phase. METHODS: Retrospective cohort study covering Medicare fee-for-service (FFS) beneficiaries. We separated out elderly residents in nursing homes (NH) and those with end-stage renal disease (ESRD) from the primary study population of individuals ages ≥65. Outcomes included COVID-19 hospital encounters and COVID-19-associated deaths. We estimated adjusted odds ratios (ORs) using logistic regression. RESULTS: We analyzed 25,333,329 elderly non-NH non-ESRD beneficiaries, 653,966 elderly NH residents, and 292,302 ESRD patients. COVID-related death rates (per 10,000) were much higher among elderly NH residents (275.7) and ESRD patients (60.8) than the primary study population (5.0). Regression-adjusted clinical predictors of death among the primary population included immunocompromised status (OR: 1.43), frailty index conditions such as cognitive impairment (3.16) as well as other comorbidities including congestive heart failure (1.30). Demographics-related risk factors included male sex (1.77), older age (OR: 3.09 for 80-year-old vs. 65-year-old), Medicaid dual-eligibility status (2.17) and racial/ethnic minority. Compared to Whites, ORs were higher for Blacks (2.47), Hispanics (3.11), and Native Americans (5.82). Results for COVID-19 hospital encounters were consistent. CONCLUSIONS: Frailty, comorbidities, and race/ethnicity were strong risk factors of COVID-19 hospitalization and death among the U.S. elderly.

A c c e p t e d M a n u s c r i p t 4 processed claims allowing for rapid outcome detection and near real-time analysis. We obtained beneficiaries' demographics and enrollment information from Centers for Medicare and Medicaid Services (CMS) Enrollment Database (EDB), the Common Medicare Environment (CME), and Master Beneficiary Summary File (MBSF). We used the Minimum Data Set (MDS) to ascertain Medicare beneficiaries' nursing home (NH) residence status, American Community Survey (ACS) data to assess population density, and Area Deprivation Index (ADI) data to assess the socioeconomic deprivation of beneficiaries' place of residence [13] .

The study begin date was April 1, 2020, since the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis code specific for COVID-19 (U07.1) became effective on this date, and COVID-19 coding practices were not standardized prior to then. The population included Medicare beneficiaries continuously enrolled in Medicare Parts A and B Fee-for-Service (FFS) for at least six months prior to study begin date who did not have any COVID-related hospitalizations (ICD-10-CM diagnosis code U07.1 or B97.29) during this period. We stratified beneficiaries into three mutually-exclusive populations: elderly NH, ESRD (including all ages), and the general elderly. We considered beneficiaries as elderly NH resident if they were ages >65 years at study begin date, resided in a NH anytime in the previous 6 months, and had no records suggesting official discharge. We defined beneficiaries with ESRD as those with at least one dialysis facility claim with no indication of acute kidney injury in the three months prior to study begin date. The primary study population was beneficiaries ages >65 years not in NH without ESRD (general elderly); a detailed elderly NH residents report will be the subject of a follow-up publication.

Outcomes included COVID-19 hospitalizations, COVID-related deaths, and COVID-related hospitalization complications: intensive care unit/coronary care unit (ICU/CCU) admission, ventilator use, inpatient renal replacement therapy, and inpatient death. We defined incident A c c e p t e d M a n u s c r i p t 5 hospitalizations as those with an inpatient discharge diagnosis of COVID-19 (diagnosis code U07.1) and admission date between April 1, 2020 and May 8, 2020. Additionally, eligible cases must not have had a previous potential COVID-19 hospitalization (with diagnosis code U07.1 or B97.29) in the six months prior to study begin date. We defined COVID-related deaths as deceased patients with a prior COVID-19 discharge diagnosis on a facility claim or at least two professional service claims with COVID-19 diagnosis code within 21 days of the death date. The facility claim or professional service claim immediately preceding the death date must have occurred during the study period of April 1, 2020 to May 8, 2020.

We assessed demographic and socioeconomic characteristics using enrollment data, chronic conditions using ICD-10-CM diagnosis codes, specific therapies and treatments using the International Classification of Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS) codes, and Healthcare Common Procedure Coding System (HCPCS) codes on inpatient and outpatient claims (including influenza vaccination) in the 6 months prior to study begin date. We calculated county-level COVID-19 circulation rates among Medicare beneficiaries using COVID-19 diagnoses in any setting. The Area Deprivation Index (ADI) rank, a scale of 1-100 measuring relative socioeconomic disadvantage with higher ADI score indicating higher socioeconomic disadvantage, was assessed using beneficiaries' residence information at the census block group level [13] . We assessed the effects of frailty on COVID-related outcomes using individual clinical conditions and health service utilization from the frailty index, a composite score measuring the probability a person is frail [14, 15] , and immunocompromised status using administrative codes indicating presence of immunocompromising conditions or use of immunosuppressive therapies [16] .

A c c e p t e d M a n u s c r i p t 6

We calculated COVID-19 hospitalization and COVID-related death rates among all eligible beneficiaries, and proportions of complications during COVID-19 hospitalization among those who were hospitalized.

We summarized proportions of COVID-related deaths and COVID-19 hospitalizations overall and stratified by covariates of interest among the primary study population. We also used multivariate logistic regression models to estimate differences in odds ratios (ORs) and 95% confidence intervals (CIs) of the study outcomes. We modeled continuous variables such as age and ADI rank using natural splines to approximate their non-linear effects, and log-transformed COVID-19 circulation rates and population density to normalize their distribution and allow for easier interpretation of their effects; we included twoway interaction terms of age, Medicare-Medicaid dual-eligibility and race. We also performed analyses where (1) the individual conditions from the frailty index were substituted with a continuous composite score, and (2) an alternative classification of race/ethnicity was used. We derived the alternative race/ethnicity classification using an algorithm combining beneficiaries' last name and residence information, mainly oriented towards the identification of Hispanics and Asian/Pacific Islanders [17, 18] .

The study analyzed a total of 30,284,193 Medicare FFS-enrolled beneficiaries. Among the three study populations of interest, COVID-19 hospitalization and death rates were the highest among the 653,966 elderly NH residents with 19,637 hospitalizations (300.3 hospitalized cases per 10,000 beneficiaries) and (Table 1) . Of all 12,613 COVID-related deaths, approximately 33.9% did not occur in the hospital and 20.3% were deaths following a hospital discharge, often occurring in hospice or nursing home facilities (Supplementary Table 1) . Table 2 summarizes the demographics, socioeconomic status characteristics, and health status of the primary study population. Among them, over half were between the ages of 65 and 74 (55.8%) and over half were female (55.6%). Most were White (85.1%), not dual-eligible for Medicaid (90.6%), and qualified for Medicare due to old age (90.5%). Compared with the overall population, beneficiaries who died with a prior COVID-19 diagnosis were disproportionately older (>85 years old: 44.5% vs. 12.6%), male (51.5% vs. 44.4%), and non-White (27.6% vs. 14.9%). They were also more likely to be dualeligible (29.0% vs. 9.4%) and to have qualified for Medicare due to disability (14.1% vs. 9.5%).

Beneficiaries hospitalized with COVID-19 had similar demographic and socioeconomic characteristics as those who died. Common pre-existing comorbidities among the study population included hypertension, diabetes, obesity, frailty-related conditions such as musculoskeletal problems, respiratory diseases such as chronic obstructive pulmonary disease (COPD), and cardiovascular diseases such as atrial fibrillation.

Prevalence of these conditions was often higher among those who died or were hospitalized with COVID-19 than the overall primary study population. Both COVID-19 deaths and hospitalizations were disproportionately distributed in areas with high COVID-19 circulation rates, high population density, and known early outbreak centers such as New York, New Jersey, Massachusetts, Illinois, and Michigan.

Of the 25,333,329 beneficiaries in the primary study population, 24,367,476 beneficiaries with complete demographic and residence information were included in the logistic regression analysis. In assessing the association of COVID-related death and COVID-19 hospitalization with potential risk factors, the study A c c e p t e d M a n u s c r i p t 8 found elevated risk of COVID-related outcomes among those who were older, male, dual-eligible for Medicaid, disabled, and those who had specific health-related risk factors (Table 3) .

Health-related factors that were associated with higher COVID-related death included being immunocompromised (OR: 1.43, 95% CI: 1.34-1.53), having medical conditions from the frailty index and other chronic conditions. Most conditions from the frailty index were associated with an increased risk of COVID-related death. Among them, cognitive impairment (3.16, 95% CI: 3.02-3.31), pneumonia (1.89, 95% CI: 1.79-2.00), and paranoia (1.66, 95% CI: 1.54-1.80) were highly associated with the outcome. Other comorbidities associated with higher risk included congestive heart failure (1.30, 95% CI:

1.23-1.36), diabetes (1.23, 95% CI: 1.18-1.29), and COPD (1.14, 95% CI: 1.08-1.20). Results for COVID-19 hospitalizations were largely consistent (Table 3) .

Consistently for both COVID-related death and COVID-19 hospitalization, being a racial or ethnic minority, dual-eligible and older were generally associated with higher risk, with the magnitude of the difference varying across subgroups (Table 3, Figure 1 ). Overall, the risk of COVID-related death was higher among beneficiaries who were dual-eligible ( Table   2 ).

Sensitivity analysis results using the alternative race categorization yielded similar results to the primary analysis, where being a minority was generally associated with higher COVID-related outcome risk compared to Whites. Under the alternative race classification, proportion of Hispanics tripled and the differences in risk between Hispanics and non-Hispanic Whites were smaller (Supplementary Table 3 , 4, 5) . Consistent with the results using individual conditions from the frailty index, our sensitivity analysis results using the frailty index found 58% increased odds of COVID-related death with every additional 10% increase in the probability a person is frail (95% CI: 1.55-1.60) (Supplementary Table 6 ). When age effects were estimated incorporating the five-year average frailty index of the particular age, the increase in COVID-related outcome risk with advancing age became greater (Supplementary Figure 2) .

A c c e p t e d M a n u s c r i p t

In the largest nationwide study on the risk of COVID-19 hospitalization and death among the U.S. elderly, we assessed with high precision the effects of a wide range of potential risk factors, including demographics, frailty, socioeconomic and health status. Our use of a frailty index allowed us to determine that overall frailty, measured using a composite score calculated from a number of health-related conditions was, by itself, highly associated with the risk of COVID-19-associated death and hospitalization (Supplementary Figure 2, Supplementary Table 6 ). The severity of COVID-19 can be highlighted by our finding that, during this early (April 1 to May 8) pandemic phase, more than a fifth of hospitalized beneficiaries in the primary study population were admitted to the ICU/CCU and over a quarter of those hospitalized died. We also found that among Medicare beneficiaries ages >65 years, COVID-19 death rates were 55 times and hospitalization rates 27 times higher among NH residents than among the primary study population, highlighting the extremely large risk among NH residents. Rates among beneficiaries with ESRD were also very high (Table 1) .

Our single-payer fee-for-service Medicare data, which likely constitutes the most representative nationwide sample of U.S. elderly, allowed us to obtain precise, adjusted estimates of COVID-19 risk for almost 100 risk categories, and also allowed us to precisely quantify interactions for age, race and dualeligibility. We found that being immunocompromised (which also includes hematological cancers and solid tumors under treatment), frail (having conditions including but not limited to cognitive impairment, pneumonia, paranoia), having comorbidities such as congestive heart failure, COPD, and diabetes or being male were associated with very high odds of COVID-related death and hospitalization (Table 3) .

These associations were generally consistent with those described in prior publications, [3, [5] [6] [7] [8] [9] [10] [11] despite some differences in the populations investigated and analysis periods. Also, our study accounted for multiple additional conditions and important interactions (Table 3) . Of particular interest are our findings A c c e p t e d M a n u s c r i p t 11 of lower risk estimates for hypertension, obesity and asthma than prior studies [3, [5] [6] [7] [8] [9] [10] [11] . Our use of adjustments for multiple risks factors may explain the differences found. The lack of association between asthma and risk of COVID-related death in our results requires further evaluation, including an examination of the potential role of asthma treatments.

Our finding that COVID-19 hospitalization and death disproportionately affected Native Americans, Hispanics and Blacks, including but not limited to those sufficiently poor to be eligible for dual Medicare/Medicaid coverage were more granular than comparable results obtained by others [19, 20] . We found that Native Americans had the highest risk estimates, both among dual-and non-dual-eligible, which suggests the need to investigate the possibility of disparities not measured exclusively by income level. We also found that Asians shared the lowest risks with Whites, which also requires further investigation. Interestingly, the risk differences by race and dual-eligibility status became less pronounced among the very old, highlighting the fact that, independently of race or socioeconomic conditions, frailty appeared to play a major role among those ages >80 years, although other explanations, such as survivor effect, could also be considered.

Our study has several strengths. Using longitudinal data on Medicare beneficiaries' pre-existing health conditions and health services utilization, we defined a wide range of potential COVID-related risk factors among individuals who were unlikely to change insurance affiliation, which allowed us to produce highly precise, adjusted estimates. Additionally, we had granular geographical and demographic information, which allowed us to study risk factors while adjusting for local infection intensity (at the county level) and individual characteristics. Given that Medicare covers the vast majority of U.S. citizens ≥65 years old, our findings are generalizable to the U.S. elderly and should particularly contribute to the understanding of COVID-19 death risk among all elderly [21] . Reassuringly, our overall hospitalization A c c e p t e d M a n u s c r i p t 12 rates and our finding that rates of hospitalization and death increased with age were comparable to those obtained by CDC for a slightly larger pandemic period, and with findings from a 12 U.S. states study [19, 20] .

Our study had some limitations. The use of administrative claims data to identify COVID-19 cases may result in the inclusion of some non-test-confirmed cases. To minimize the potential misclassification bias, we used inpatient discharge diagnoses for identifying outcomes, which were found to have high accuracy in prior literature [22, 23] . The high attention paid to the COVID-19 pandemic and the seriousness of the events we investigated gives us high confidence that physicians and hospitals were likely to follow CDC's guidelines regarding COVID diagnosis. Although we used the binary Medicaid dual-eligibility status as the proxy for low-income status, this does not provide granular information on people's income level. However, the dual-eligibility status is available for all beneficiaries, highly accurate in identifying low-income individuals, and has been successfully used as poverty surrogate in multiple studies [24] [25] [26] [27] [28] [29] [30] .

Lastly, our race/ethnicity classification is based on Medicare enrollment data, which under-captures Hispanics and Asians. However, this variable is highly accurate in distinguishing Blacks from Whites, two of the largest racial/ethnic groups in our population. Additionally, our main study results were similar to those of the sensitivity analysis we conducted using an alternative race/ethnicity classification that captured more Hispanics and Asians (Supplementary Table 3 ) [17] . Our results were, overall, also consistent with prior U.S. studies published on the same topic [3, [5] [6] [7] [8] [9] [10] [11] .

A c c e p t e d M a n u s c r i p t 13 In conclusion, this large nationwide cohort study among the U.S. elderly confirmed and precisely measured the importance of several risk factors, including particularly NH residence, ESRD status, older age, male sex, racial/ethnic minorities, immunocompromised status, frailty and chronic conditions. Moreover, our study found that social disparities (i.e., socioeconomic factors) were highly associated with an increased risk of COVID-related outcomes, even after adjusting for factors such as age and chronic medical conditions, highlighting the need to consider the interconnected effects of poverty and race/ethnicity in evaluations of COVID-19 risk. Our study demonstrates the benefits of using real-world evidence for the timely evaluation of risk factors for severe disease during pandemics and epidemics, and its potential to contribute to public health decision-making. M a n u s c r i p t

Coronavirus COVID-19 Global Cases Available at

Update: Public Health Response to the Coronavirus Disease

Coronavirus Disease 2019 Case Surveillance -United States

Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak -United States

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 -COVID-NET, 14 States

Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 -Georgia

Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 -United States

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) -United States

Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study

Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis %J Research

Neighborhood Atlas: Area Deprivation Index

External validation of the claims-based frailty index in the national health and aging trends study cohort

Development of a Claimsbased Frailty Indicator Anchored to a Well-established Frailty Phenotype

Validation of a Method to Identify Immunocompromised Patients with Severe Sepsis in Administrative Databases

More accurate racial and ethnic codes for Medicare administrative data

Validity of Race and Ethnicity Codes in Medicare Administrative Data Compared With Gold-standard Self-reported Race Collected During Routine Home Health Care Visits

To Jing Wang, Angela Cheng, and Yuxin Ma, Acumen LLC, for contributions to statistical programming.To Jiemin Liao and Ellie Smith, Acumen LLC, for contribution to manuscript writing and review.

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t